Alanine Aminotransferase (ALT/GPT) Activity Assay Kit
中文名称：谷丙转氨酶（ALT/GPT）比色法测试盒
Price:
Size:
100 Assays (44 samples)
50 Assays (19 samples)
- 样本类型： 血清（浆）;动物组织;细胞
- 检测仪器及波长： 紫外-可见光分光光度计（505 nm）
- 研究领域： 肝肾功能
该指标在测定组织或细胞样本时，需要测定样本的总蛋白含量，推荐使用BCA法测蛋白，货号E-BC-K318-M
说明书或网站上未涉及的样本类型请先跟技术支持沟通，可进行售前验证
根据需测样本数，试剂盒测样本孔数和单个样本测量孔数来计算所需生化试剂盒数量，请点击按钮 计算
| 检测原理 |
在37°C、pH7.4条件下，谷丙转氨酶（ALT）催化丙氨酸与α-酮戊二酸之间的氨基转换反应，生成丙酮酸和谷氨酸，反应时间过后，加入苯肼，与丙酮酸生成苯腙，苯腙在碱性条件下呈红棕色。
|
| 指标简称 | ALT |
| 灵敏度 | 1.26 IU/L |
| 检测范围 | 1.26-72.3 IU/L |
| 精密度 | 批间差：8.2% | 批内差：4.3% |
| 样本量 | 0.2 mL |
| 检测时间 | 1 h 40 min |
| 检测仪器及波长 | 紫外-可见光分光光度计（505 nm） |
| 保存条件 | 该产品可在 2-8°C避光条件下保存6个月。 |
| 有效期 | 6个月 |
-
Xylopia aethiopica Attenuates Oxidative Stress and Hepatorenal Damage in Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats
IF: 0.3Journal： Journal of Health and Allied Sciences NU (2024) -
Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis
IF: 18.9 -
Phosphomevalonate Kinase Controls β-Catenin Signaling via the Metabolite 5-Diphosphomevalonate
IF: 15.100 -
Regulation of inflammatory macrophages by oral mineralized metal-organic framework nanoparticles for the synergistic treatment of ulcerative colitis and liver injury
IF: 15.100Journal： CHEMICAL ENGINEERING JOURNAL (2023)Reactivity：MouseSample Type：liver -
Zinc-Organometallic Framework Vaccine Controlled-Release Zn2+ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy
IF: 15.1 -
Thermal/ultrasound-triggered release of liposomes loaded with Ganoderma applanatum polysaccharide from microbubbles for enhanced tumour ablation
IF: 10.8 -
ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy
IF: 10.000 -
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
IF: 9.8Journal： METABOLISM-CLINICAL AND EXPERIMENTAL (2023)PMID：37422021Reactivity：MouseSample Type：serum -
Multifaceted Nano-DEV-IL for Sustained Release of IL-12 to Avert the Immunosuppressive Tumor Microenvironment and IL-12-Associated Toxicities
IF: 9.500 -
Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis
IF: 9.0
暂无文件，请在搜索框输入识别码查询相关文件
| 名称 | 状态 | 有效期至 | 操作 | |
|---|---|---|---|---|
| {{item.文件名}} | {{item.status_str}} | {{item.timestamp_str}} | 点击查看 点击预览 |
*注：请在有效期内下载相关文件，过期后页面内将不提供文件下载及预览！
积分商城
微信公众号
在线咨询